Articles with "design expert" as a keyword



Design Expert Analysis of Tacrolimus Compatibility with Common Excipients.

Sign Up to like & get
recommendations!
Published in 2025 at "Drug development and industrial pharmacy"

DOI: 10.1080/03639045.2025.2586762

Abstract: Abstract Objective Tacrolimus is a potent macrolide immunosuppressant widely utilized in solid organ transplantation and the management of autoimmune disorders. The current study aimed to investigate the compatibility of tacrolimus with four commonly used excipients,… read more here.

Keywords: design expert; compatibility; tacrolimus; analysis ... See more keywords

DESIGN EXPERT SUPPORTED FORMULATION DEVELOPMENT, MATHEMATICAL OPTIMIZATION AND PREDICTABILITY STUDY OF FLOATING TABLETS OF BISOPROLOL FUMARATE

Sign Up to like & get
recommendations!
Published in 2021 at "International Journal of Applied Pharmaceutics"

DOI: 10.22159/ijap.2021v13i2.40433

Abstract: Objective: Focus of the study was to formulate Design expert Software assisted floating tablet of Bisoprolol Fumarate. Bisoprolol Fumarate is a Beta adrenergic blocking agent, used to treat cardiac diseases favorable characters to be formulated… read more here.

Keywords: bisoprolol fumarate; formulation; study; design expert ... See more keywords

Formulation development and optimization of orally disintegrating tablets of montelukast sodium by Design- Expert

Sign Up to like & get
recommendations!
Published in 2018 at "Tropical Journal of Pharmaceutical Research"

DOI: 10.4314/tjpr.v17i9.3

Abstract: Purpose: To prepare orally disintegrating tablets (ODT) of montelukast sodium using Design-Expert for improved patient compliance. Methods: Central composite design was selected to delineate and optimize the formulations. Concentrations of crospovidone (X 1 ) and… read more here.

Keywords: disintegrating tablets; montelukast sodium; orally disintegrating; sodium ... See more keywords

Design Formulation and in vitro Evaluation of Gastroretentive Microspheres of Selegiline Hydrochloride for Parkinson’s Disease by Design Expert

Sign Up to like & get
recommendations!
Published in 2024 at "Indian Journal of Pharmaceutical Education and Research"

DOI: 10.5530/ijper.58.1s.31

Abstract: Introduction: Selegiline hydrochloride is primarily used to treat Parkinson’s disease. Selegiline hydrochloride mucoadhesive microspheres were prepared to improve the bioavailability of the drug and its appropriate therapeutic performance. Materials and Methods: The ionic gelation process… read more here.

Keywords: formulation; design expert; drug; selegiline hydrochloride ... See more keywords